Head-to-head · Cost-Efficiency Index
NiceRx vs Aspen
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
NiceRx
Cost-first shoppers who want a clearly disclosed standing month-to-month rate rather than a prepay-gated one.
Visit NiceRxAspen
Cost-first shoppers who want wanting one flat price regardless of whether treatment ends up being semaglutide or tirzepatide, if willing to commit to 3 months.
Visit AspenThe verdict
NiceRx takes it, leading the Cost-Efficiency Index 76 to 74. NiceRx is a compounded GLP-1 telehealth platform charging $199/mo for semaglutide and $299/mo for tirzepatide on an ongoing month-to-month basis (first month discounted to $99 and $199 respectively). Aspen still earns a C — Cost-first shoppers who want wanting one flat price regardless of whether treatment ends up being semaglutide or tirzepatide, if willing to commit to 3 months.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs NiceRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | NiceRx | Aspen |
|---|---|---|
| Cost-Efficiency Index | 76/100 | 74/100 |
| Semaglutide / mo | $199/mo (all doses, compounded) | $179/mo (all doses, compounded) |
| Tirzepatide / mo | $299/mo (all doses, compounded) | $179/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,148 |
| Tirzepatide / yr (modeled) | $3,588 | $2,148 |
| Coverage | 46 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #50 | #57 |
NiceRx
76/100Where the value is
- Explicitly discloses both the promotional first-month price and the real ongoing 'every month thereafter' rate on the same page, rather than only advertising the promo
- Flat pricing across all doses, with the provider visit and shipping bundled into the price
- Cancel-anytime billing with no long-term commitment structure found
The tradeoffs
- Not available in Alaska, Mississippi, New Jersey, or Kansas
- Compounded only — no FDA-approved brand option
Aspen
74/100Where the value is
- One transparent, dose-independent flat price ($179/mo) covers either the semaglutide or tirzepatide path, avoiding the tirzepatide surcharge most compounded competitors charge
- Price stated to be all-in: provider consultation, custom dosing, medication, and free delivery bundled with no listed add-on fees
- No insurance required, cash-pay simplicity
The tradeoffs
- The bold '$179/mo' headline omits its own fine-print condition — a 3-month commitment — visible only in small text directly beneath the price
- Almost nothing else is disclosed on the public site: no states-served list, no named medical director or prescriber, no named pharmacy, and no LegitScript certification found
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.